A new study is showing that the new class of weight loss drugs like Ozempic and Wegovy may help lower the risk of 10 different obesity-related cancers. Dr. Roshini Raj joins TODAY to break down the findings.
A daily weight loss pill from Novo Nordisk was shown to lower body weight by up to 13% after three months in a Phase 1 clinical trial, according to findings presented Tuesday at the European Association for the Study of Diabetes annual meeting in Spain. The rate of weight loss with the experimental pill, called amycretin, appears to be more rapid than what’s seen for other drugs.
Researchers also tested multiple doses of the drug, including increasing some participants’ dose levels over time. The goal of a Phase 1 trial is to look at the safety of a new drug, including determining what doses work best for patients. Later trials focus on how well the drug works. That having been said, people who got the weight loss drug did lose weight: After 12 weeks, participants on the highest dose had lost an average of 13.1% of their body weight, compared with an average loss of 1.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
People Are Overdosing on Semaglutide Drugs like Ozempic and WegovyDosing errors in the medication semaglutide, prescribed as Wegovy and Ozempic, can cause severe or prolonged gastrointestinal issues that require medical attention
Read more »
7 Risks of Ozempic and Wegovy Overuse as Cases Spikestrong|Title/strong|: Writer strong|Location/strong|: Los Angeles strong|Education/strong|: BA in History, Politics, and Economics from Royal Holloway, University of London strong|Expertise/strong|: Health, Science, and Wellness strong|Experience/strong|: Ferozan has 20 years of experience writing and editing in the health, wellness,...
Read more »
Ozempic vs Wegovy: The Risks And Side Effects of Semaglutide DrugsThe Best in Science News and Amazing Breakthroughs
Read more »
Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, Studies FindNew trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways.
Read more »
How Ozempic, Wegovy, Mounjaro, Zepbound May Help Treat Other Diseases: Here’s What To KnowArianna Johnson is a reporter on the Forbes news desk who covers explainers and trends, with a frequent focus on health and science. She joined Forbes in 2022 and works in Texas. Johnson has covered prominent weight loss drugs like Ozempic and Wegovy, the health effects of the artificial sweetener aspartame and the impacts of the Covid vaccines.
Read more »
Pennsylvania mom Juanita Gantt files lawsuit against drugmaker claiming Ozempic and Wegovy nearly killed herToday's Video Headlines: 9/4/24
Read more »